PEG products with additional MW may be made to order, please contact us for details
3arm PEG Amine (glycerol), HCl salt
$60.00 – $480.00
Description
3arm PEG Amine (glycerol), HCl salt, reagent with superior quality specification of ≥ 95% Substitution.
JenKem Technology’s 3arm PEG Amine derivatives can be cross-linked into PEG hydrogels. PEG hydrogels have a variety of applications in medical devices and regenerative medicine, and are especially of interest for controlled release of drugs, for 3D cell culture, and for wound sealing and healing. JenKem Technology’s 3 arm PEGs are synthesized by ethoxylation of glycerol. The number of ethylene oxide units in the PEG chain may not be equal for all arms. The total molecular weight reported for the JenKem multi-arm PEGs is the sum of the molecular weights of all arms.
Multi-arm star PEG products with molecular weights, branching, and functional groups not listed in our online catalog may be available by custom synthesis. Please inquire at tech@jenkemusa.com about pricing and availability.
Bulk PEGs and GMP grade PEGs are made-to-order. Please contact us for bulk pricing.
References:
1. Song, J, et al, Influence of Poly (ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood. ACS nano. 2021.
Note: Starting July 2016, 3ARM-NH2HCl is the new item number of the product 3ARM NH2 (MW 15K (3ARM-NH2-15K) and MW 20K (3ARM-NH2-20K)).
Founded in 2001 by experts in PEG synthesis and PEGylation, JenKem Technology specializes exclusively in the development and manufacturing of high quality polyethylene glycol (PEG) products and derivatives, and related custom synthesis and PEGylation services. JenKem Technology is ISO 9001 and ISO 13485 certified, and adheres to ICH Q7A guidelines for GMP manufacture. The production of JenKem® PEGs is back-integrated to in-house polymerization from ethylene oxide, enabling facile traceability for regulated customers. JenKem Technology caters to the PEGylation needs of the pharmaceutical, biotechnology, medical device and diagnostics, and emerging chemical specialty markets, from laboratory scale through large commercial scale.